| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.14 | 0.4 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.4 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.4 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |